LISATA THERAPEUTICS INC (LSTA:NASDAQ)
$3.56 0.08 (2.2989%)
Analysed LISATA THERAPEUTICS INC (LSTA:NASDAQ) News Sources
Lisata Therapeutics Inc (LSTA) Q3 2025 Earnings Call Highlights: Strategic Alliances and Cost ...
07-11-2025
yahoo.com
LSTA Releases Valuations Report on Level 3 Loans
04-12-2025
yahoo.com
Lisata Therapeutics Enters Into Term Sheet to be Acquired by Kuva Labs for $4.00 Per Share in an All-Cash Tender Offer
21-01-2026
yahoo.com
How The Evolving Story For Lisata Therapeutics (LSTA) Is Reshaping Its Valuation Outlook
22-01-2026
yahoo.com
Lisata Therapeutics And 2 Other Penny Stocks Worth Watching
22-01-2026
yahoo.com
Lisata Therapeutics Announces Mutual Termination of License Agreement with Qilu Pharmaceutical for Certepetide
27-01-2026
yahoo.com
Lisata Therapeutics Enters into Definitive Agreement to be Acquired by Kuva Labs, Inc.
06-03-2026
yahoo.com
Lisata Therapeutics shares up 20% as Kuva Labs acquisition advances
09-03-2026
proactiveinvestors.com
Lisata Therapeutics Announces Commencement of Tender Offer by Kuva Labs Inc.
10-06-2026
yahoo.com
Lisata Therapeutics agrees to Kuva Labs buyout at $4 per share
10-06-2026
proactiveinvestors.com
What is the current price of LISATA THERAPEUTICS INC (LSTA:NASDAQ)?
The current price of LISATA THERAPEUTICS INC (LSTA:NASDAQ) is $3.56.
LISATA THERAPEUTICS INC (LSTA:NASDAQ) absolute price change since previous trading day?
The absolute price change of LISATA THERAPEUTICS INC (LSTA:NASDAQ) since the previous trading day is $0.08.
LISATA THERAPEUTICS INC (LSTA:NASDAQ) percentage price change since previous trading day?
The percentage price change of LISATA THERAPEUTICS INC (LSTA:NASDAQ) since the previous trading day is 2.2989%.
What is the most recent average sentiment score for LISATA THERAPEUTICS INC (LSTA:NASDAQ)?
The most recent average sentiment score for LISATA THERAPEUTICS INC (LSTA:NASDAQ) is 80 out of 100.
What is the most recent average sentiment for LISATA THERAPEUTICS INC (LSTA:NASDAQ)?
The most recent sentiment for LISATA THERAPEUTICS INC (LSTA:NASDAQ) is .
SEC-8K** Filing Available For LISATA THERAPEUTICS INC (LSTA:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.